Loading clinical trials...
Loading clinical trials...
Throughput and Disposition Metrics When Using Dsuvia as a Bridging Medication to Decrease Time to Analgesia and Hospital Admissions in Patients With Sickle Cell Disease Vaso-Occlusive Crisis That Present to the Emergency Department
Conditions
Interventions
sublingual sufentanil
Locations
1
United States
Tampa General Hospital
Tampa, Florida, United States
Start Date
March 30, 2022
Primary Completion Date
April 1, 2023
Completion Date
December 1, 2023
Last Updated
May 24, 2022
Lead Sponsor
Jason Wilson
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions